AstraZeneca, Bristol Myers Squibb Hold Preliminary Talks on Potential $400 Billion Pharma Merger
LONDON: British pharmaceutical giant AstraZeneca has held preliminary discussions with U.S.-based Bristol Myers Squibb over a potential merger that could…